Adjuvant Immunotherapy in the Modern Management of Resectable Melanoma: Current Status and Outlook to 2028.M Donia, H Jespersen,M Jalving, R Lee, H Eriksson,C Hoeller, M Hernberg, I Gavrilova, L Kandolf,G Liszkay, H Helgadottir,A Zhukavets, D Pianova,I Marquez-Rodas,B Neyns, H Westgeest, I Pourmir,P Sobczuk,E Ellebaek,T AmaralESMO open（2025）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
